Search results
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 18 hours agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoCAR-T drugs are developed using a patient's own immune cells. Promisingly, Pfizer said in February...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 5 days agoWilliam Blair analyst...backlogs, today's news does not alter our expectation that (Moderna's RSV ...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 2 days agoModerna emphasized the FDA has not said it found any issues related to vaccine effectiveness, safety...
AstraZeneca withdraws Covid-19 vaccine, citing low demand - Boston News, Weather, Sports | WHDH...
7 News Boston· 7 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 2 days agoThe deal is a negative for Covid vaccine rivals Pfizer and Moderna, Leerink Partners analyst David...
AstraZeneca's COVID vaccine withdrawn—it was a victim of misinformation right to the end, researcher...
Medical Xpress· 6 days agoThis development has been covered in various media outlets as primarily related to the known...
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe speed and flexibility required in clinical trials for COVID-19 set a new precedent for what can...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoThe Food and Drug Administration (FDA) notified Moderna Inc MRNA on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints ...
A Novel Broad-Spectrum Antiviral with Activity Against RSV
Digital Journal· 2 days agoSHELTON, CT / ACCESSWIRE / May 14, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV ...